| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 8e-07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.002 |